IDTechEx Examines the Opportunities for Wearables in Digital Health
April 19, 2024 | IDTechExEstimated reading time: 3 minutes
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred – medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications as a key focus for their wearable products. IDTechEx’s report, “Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook”, covers this ongoing trend in the consumer health wearables market and includes analysis of the opportunities and roadmap for biometric monitoring.
Consumer devices battle for medical applications
A direction of travel that has been evident in the wearables industry is the increase in health metrics monitored by smartwatches. A key development in February 2024 was the clearance by the US regulatory body, the Food and Drug Administration (FDA), of the Samsung Galaxy Watch app for the assessment of sleep apnea risk. Sleep apnea is a serious sleep disorder that has significant health implications but is often undiagnosed. The ability to detect silent health conditions via a consumer device has the potential to create improvements in quality of life for a significant population of users. Upcoming consumer electronics, particularly new form factors such as smart rings, promise to bring even more health monitoring capabilities.
Underpinning the sleep apnea detection algorithm are optical sensors capable of detecting the wearer’s blood oxygen levels. While the FDA clearance is significant, the truth is that consumers have been able to check their quality of sleep for signs of sleep apnea, including movement, respiratory rate, and blood oxygen, for several years. The key difference is that with FDA clearance, the devices are no longer categorized as “wellness devices”, which come with major warnings that the data generated are not intended for medical use.
Though there are countless biometrics that can be monitored by smartwatches and other consumer electronics, the reality is that there are only a select few medical conditions that have the potential to drive substantial numbers of new users to these products. When compared to existing diagnostics or monitoring methods, consumer electronics companies will need to prove that comfortable and continuous monitoring provides significant benefit over incumbent technologies, for a large enough market.
The IDTechEx report on digital health discusses opportunities for consumer health wearables, including key value propositions and a roadmap for wearable sensor technology segmented by key biometrics. For additional information on the sensor technologies required for key medical applications in consumer electronics, please refer to the IDTechEx research report Wearable Sensors 2023 – 2033.
Medical device companies eye up the consumer market
On the other end of the spectrum, medtech companies have also been entering the consumer market. Some products, such as the Omron HeartGuide blood pressure monitoring smartwatch launched in 2019, have been specifically designed from the ground up as a consumer health wearable.
However, the key health technology that is making the switch to consumer markets comes in the form of an electronic skin patch. Specifically, the continuous glucose monitor, a majorly disruptive piece of health technology in the Type 1 diabetes market, has been increasingly marketed toward consumers in recent years. These began with niche markets, such as elite athletes competing in endurance sports, but have shifted now to people interested in leveraging data on their metabolism to achieve wellness goals.
Currently, Abbott’s Lingo is available in the UK to help consumers better understand their metabolism and to improve their health. In 2024, rival Dexcom received the first FDA approval to sell a CGM over the counter in the US. Called Stelo, the device will be available in the summer of 2024 and marks a major first step into the digital health for pre- and type 2 diabetes markets. IDTechEx’s report on digital health covers the intersection of the digital health, diabetes, and consumer markets and includes a 10-year forecast for the CGM market from 2024 – 2034.
Suggested Items
Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems
05/08/2025 | Cadence Design SystemsAt its annual flagship user event, CadenceLIVE Silicon Valley 2025, Cadence announced a major expansion of its Cadence® Millennium™ Enterprise Platform with the introduction of the new Millennium M2000 Supercomputer featuring NVIDIA Blackwell systems, which delivers AI-accelerated simulation at unprecedented speed and scale across engineering and drug design workloads.
Zhen Ding Releases April 2025 Monthly Revenue Report
05/07/2025 | Zhen Ding TechnologyZhen Ding Technology Holding Limited, a global leading PCB manufacturer, reported April 2025 revenue of NT$13,589 million, up 22.90% YoY, marking a record high for the same period in the company’s history.
Schweizer Electronic AG: Business Development in Q1 of 2025
05/07/2025 | Schweizer Electronic AGThe Schweizer Group continued its growth trajectory in the first quarter of 2025. Revenue reached EUR 39.4 million in the first quarter of 2025, up 14.9% on the previous quarter (Q4 2024: EUR 34.4 million) and slightly above the level of the same quarter of the previous year (Q1 2024: EUR 39.2 million).
Koh Young Invites You to the 2025 IEEE Electronic Components and Technology Conference
05/06/2025 | Koh YoungKoh Young, the industry leader in True3D™ measurement-based inspection solutions, invites you to join us at the 2025 IEEE Electronic Components and Technology Conference (ECTC), taking place May 27–30, 2025, at the Gaylord Texan Resort & Convention Center in Grapevine, Texas
Global Semiconductor Sales Increase 18.8% in Q1 2025 Compared to Q1 2024; March 2025 Sales up 1.8% MoM
05/06/2025 | SIAThe Semiconductor Industry Association (SIA) announced global semiconductor sales were $167.7 billion for the first quarter of 2025, an increase of 18.8% compared to the first quarter of 2024 but 2.8% less than the fourth quarter of 2024.